Cytotoxic drugs in primary glomerular disease

Health care reforms in America: perspectives, comparisons and realities.

QJM : monthly journal of the Association of Physicians·2010

Glomerular therapeutics: looking back, looking forward.

Heart disease (Hagerstown, Md.)·2002

Nephrology in the 21st century: revolutionary changes.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2000

The treatment of IgA nephropathy: status at the end of the millenium.

Journal of nephrology·2000

Glomerular disease in the elderly population.

Geriatric nephrology and urology·1999

Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy.

Kidney international·1998

Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.

Proceedings of the Clinical Dialysis and Transplant Forum·1980

Acid-base balance in continuous ambulatory peritoneal dialysis.

Proceedings of the Clinical Dialysis and Transplant Forum·1980

Improved results in high risk cadaveric kidney transplantation.

Proceedings of the Clinical Dialysis and Transplant Forum·1980

Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer.

ACS omega·2026

Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.

JTO clinical and research reports·2026

Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice.

JTO clinical and research reports·2026

Use of the Behavioral Dyscontrol Scale-2 (BDS-2) to measure executive dysfunction in FXTAS.

Frontiers in molecular neuroscience·2026

Targeted niosomes protect the heart from doxorubicin-induced injury: evidence from oxidative stress, pyroptosis, and apoptosis pathways.

3 Biotech·2026

From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors.

Frontiers in oncology·2026

Related Experiment Videos

Cytotoxic drugs in primary glomerular disease

Related Concept Videos

Health care reforms in America: perspectives, comparisons and realities.

Glomerular therapeutics: looking back, looking forward.

Nephrology in the 21st century: revolutionary changes.

The treatment of IgA nephropathy: status at the end of the millenium.

Glomerular disease in the elderly population.

Differential response of glomerular epithelial and mesangial cells after subtotal nephrectomy.

Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.

Acid-base balance in continuous ambulatory peritoneal dialysis.

Improved results in high risk cadaveric kidney transplantation.

Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer.

Comparative Treatment Outcomes Across Actionable Genomic Alterations in NSCLC: A Large Multicenter Real-World Study.

Development and Characterization of a Patient-Derived KIF5B-RET Fusion Lung Adenocarcinoma Cell Line for Subcutaneous and Central Nervous System Tumor Models in Immunodeficient Mice.

Use of the Behavioral Dyscontrol Scale-2 (BDS-2) to measure executive dysfunction in FXTAS.

Targeted niosomes protect the heart from doxorubicin-induced injury: evidence from oxidative stress, pyroptosis, and apoptosis pathways.

From dual inhibition to precision selectivity: the molecular rationale and clinical evolution of next-generation PARP1-selective inhibitors in solid tumors.

Related Experiment Videos

Cytotoxic drugs in primary glomerular disease

Related Concept Videos

Related Articles